Unclear ownership often leaves survivors without support, and coverage of social and psychological services could close the gap, says Bhatnagar.
|Videos|December 24, 2019
This Week in Managed Care: The Top Stories of 2019
AJMC® presents the results of our online poll of the top healthcare stories of 2019.
Advertisement
Welcome to This Week in Managed Care. I’m Christina Mattina with a special year-end edition.
Here are the results of our online poll of the top healthcare stories for 2019.
Number 5. A judge strikes down
Number 4. The uninsured rate
Number 3. Doctors link a
Number 2. An appeals court
Number 1. Dr Scott Gottlieb
For a review of our top articles of 2019, visit ajmc.com.
For all of us at AJMC®, thanks for watching this year, and join us in 2020.
Advertisement
Related to this article
Jennifer Flythe, MD, MPH, discusses individualizing dialysis volume management and why guideline-directed therapy use lags in advanced CKD.
At IDWeek 2026, IDSA and HIVMA leaders and clinician advocates outline how stories, relationships, and bipartisan outreach shape ID and HIV policy.
At IDWeek 2026, Atul Gawande, MD, MPH, said USAID cuts are costing lives but that the field is "not back at square one."
Oncologists weighted how to choose, manage, and deliver new therapeutics beyond major academic centers.
As CKCC nears its sunset, kidney care leaders urge CMS to preserve a dedicated, nephrologist-led accountable care model for advanced kidney disease.
Insurance barriers were the top reason 4 in 10 people prescribed long-acting PrEP at a Missouri clinic never received it, an IDWeek 2026 poster found.
In 179 patients with essential thrombocythemia, higher ropeginterferon alfa-2b exposure was linked to larger JAK2V617F allele burden drops at 6 months.
Advertisement
Advertisement
Trending on AJMC
1
Preparing for Hepatitis B Functional Cure: Jordan Feld, MD, MPH
2
IDWeek Studies Tie RSV, Flu, and COVID-19 to Harm After Acute Illness
3
FDA Approves Talazoparib Plus Enzalutamide for HRR-Mutated mHSPC
4
Povetacicept Cuts Proteinuria by 52% in IgA Nephropathy at Week 36
5